Electrical Stimulation During Immobilization (ESDIM)

This study is currently recruiting participants.
Verified March 2012 by Maastricht University Medical Center
Sponsor:
Information provided by (Responsible Party):
Lex Verdijk, Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01513486
First received: January 6, 2012
Last updated: March 14, 2012
Last verified: March 2012

January 6, 2012
March 14, 2012
March 2012
December 2012   (final data collection date for primary outcome measure)
muscle mass, muscle fiber size [ Time Frame: three days before immobilization, and directly after immobilization (day of cast removal; day 6) ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01513486 on ClinicalTrials.gov Archive Site
muscle strength measured by quadriceps 1-Repetition Maximum by Leg Extension [ Time Frame: three days before immobilization, and directly after immobilization (day of cast removal; day 6) ]
Same as current
Not Provided
Not Provided
 
Electrical Stimulation During Immobilization
The Effects of Daily Neuromuscular Electrical Stimulation on Muscle Mass During Short-term One-legged Knee Immobilization in Healthy Young Men

In the present study, the effects of 5 days of lower limb immobilization with or without daily neuromuscular electrical stimulation on muscle mass and muscle fiber characteristics will be determined.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Basic Science
  • Disuse Atrophy
  • Immobilization
  • Neuromuscular Electrical Stimulation
Behavioral: immobilization
  • Experimental: Immobilization with NMES
    Immobilization with daily NMES
    Intervention: Behavioral: immobilization
  • Placebo Comparator: Immobilization without NMES
    Immobilization without daily NMES
    Intervention: Behavioral: immobilization
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male
  • Aged from 18-35 years
  • 18.5 < BMI < 30 kg/m2

Exclusion Criteria:

  • Smoking
  • Performing regular resistance training in the previous 6 months
  • Hypertension (according to WHO criteria) [46] and/or cardiovascular disease
  • Any back/leg/knee/shoulder complaints which may interfere with the use of crutches
  • Use of any prescribed medication
  • Type 2 diabetes mellitus
  • Any family history of thrombosis
  • All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).
  • Myocardial infarction within the last 3 years
  • Use of anti-coagulants
Male
18 Years to 35 Years
Yes
Contact: Benjamin T. Wall, PhD +31-433882215 benjamin.wall@maastrichtuniversity.nl
Contact: Marlou Dirks, MSc +31-433882215 marlou.dirks@maastrichtuniversity.nl
Netherlands
 
NCT01513486
MEC 11-3-073
No
Lex Verdijk, Maastricht University Medical Center
Maastricht University Medical Center
Not Provided
Principal Investigator: Luc JC van Loon, PhD Maastricht UMC
Maastricht University Medical Center
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP